(Q36649920)

English

Impact of intravenous naltrexone on intravenous morphine-induced high, drug liking, and euphoric effects in experienced, nondependent male opioid users

scientific article published on September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Impact of intravenous naltrexone on intravenous morphine-induced high, drug liking, and euphoric effects in experienced, nondependent male opioid users (English)

1 reference

Europe PubMed Central

15 August 2017

0 references

author name string

Lynn R Webster

1

1 reference

Europe PubMed Central

15 August 2017

Franklin K Johnson

2

1 reference

Europe PubMed Central

15 August 2017

Joseph Stauffer

3

1 reference

Europe PubMed Central

15 August 2017

Beatrice Setnik

4

1 reference

Europe PubMed Central

15 August 2017

Sabrina Ciric

5

1 reference

Europe PubMed Central

15 August 2017

publication date

1 September 2011

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

11

1 reference

Europe PubMed Central

15 August 2017

3

1 reference

Europe PubMed Central

15 August 2017

259-275

1 reference

Europe PubMed Central

15 August 2017

Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

30 September 2017

Evaluation of the abuse potential of extended release hydromorphone versus immediate release hydromorphone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

30 September 2017

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

30 September 2017

Abuse-deterrent opioid formulations: are they a pipe dream?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

30 September 2017

Challenges in the development of prescription opioid abuse-deterrent formulations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

30 September 2017

Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

30 September 2017

Extended-release opioids for the management of chronic non-malignant pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

30 September 2017

Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

30 September 2017

Guidelines and methodological reviews concerning drug abuse liability assessment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

30 September 2017

Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

30 September 2017

Illicit cocaine use patterns in intravenous-naive cocaine users following investigational intravenous cocaine administration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

28 June 2018

Evaluation of the opioid addiction test in an out-patient drug dependency unit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

28 June 2018

Assessment of the abuse liability of buspirone in recreational sedative users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

28 June 2018

Relative oral bioavailability of morphine and naltrexone derived from crushed morphine sulfate and naltrexone hydrochloride extended-release capsules versus intact product and versus naltrexone solution: a single-dose, randomized-sequence, open-labe

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

20 September 2018

Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: a randomized, double-blind, placebo-

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

20 September 2018

Patterns of abuse among unintentional pharmaceutical overdose fatalities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

20 September 2018

Opioid prescriptions soar: increase in legitimate use as well as abuse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

20 September 2018

The effects of tramadol on static and dynamic pupillometry in healthy subjects--the relationship between pharmacodynamics, pharmacokinetics and CYP2D6 metaboliser status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

20 September 2018

The pupillary effects of intravenous morphine, codeine, and tramadol in volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

20 September 2018

Pharmacokinetics and pharmacodynamics of inhaled versus intravenous morphine in healthy volunteers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

20 September 2018

Opioid physical dependence development: effects of single versus repeated morphine pretreatments and of subjects' opioid exposure history

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586102

20 September 2018

Research design strategies to evaluate the impact of formulations on abuse liability

1 reference

https://pubmed.ncbi.nlm.nih.gov/21902287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk identification, risk assessment, and risk management of abusable drug formulations

1 reference

https://pubmed.ncbi.nlm.nih.gov/21902287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11593390-000000000-00000

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36649920&oldid=1643094957"